Selected as R&D for TIPS irritable bowel syndrome vesicle treatment by Korea Angel Investment Association

Selected as R&D start-up commercialization for TIPS irritable bowel syndrome vesicle treatment by Korea Angel Investment Association

1 design registration

1 patent registration

200 million and 70,000 won investment in Ulsan University Investment Association and Actner Lab Co., Ltd

1 patent registration, 1 design registration

Sign a contract for manufacturing fecal transplant solution for FMT treatment at Seoul National University Bundang Hospital

Founded 'Healbiome', a fecal bank

Selected as an alternative treatment R&D project for fecal microbiota transplantation at Seoul National University Bundang Hospital

Venture Business Certification-Small and Medium Business Corporation

The 1st Human Microbiome Conference and Forum ceremony

Established a research institute affiliated with Seoul National University Bundang Hospital to manufacture fecal transplant solution for FMT treatment

Selected as a R&D project for pharmabiotics derived from the human body by the Ministry of Science and Technology

Office relocation (172 Dolma-ro, Bundang-gu, Seongnam-si, Gyeonggi-do)

(Jungja-dong, Healthcare Innovation Park) 470 million paid-in capital increase (Capital 1.94 million won)

Incorporation